Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
519.48
455.09
341.39
192.08
192.82
324.11
432.21
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
519.48
455.09
341.39
192.08
192.82
324.11
432.21
Raw Material Cost
238.17
245.28
199.53
137.91
111.85
99.48
96.67
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
200.07
162.09
145.56
141.71
114.80
98.02
101.98
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5.26
5.83
3.93
2.72
2.36
0.15
0.16
Selling and Distribution Expenses
143.02
143.56
126.37
131.59
118.79
127.21
161.95
Other Expenses
-11.85
-7.36
-6.39
-1.39
0.15
-1.18
-2.97
Total Expenditure (Excl Depreciation)
468.01
483.16
411.48
400.02
349.28
313.03
331.10
Operating Profit (PBDIT) excl Other Income
51.5
-28.1
-70.1
-207.89999999999998
-156.5
11.100000000000001
101.1
Other Income
25.63
33.81
15.49
8.52
7.37
19.25
7.94
Operating Profit (PBDIT)
167.26
91.22
28.38
-126.65
-77.84
75.07
142.72
Interest
5.26
5.83
3.93
2.72
2.36
0.15
0.16
Exceptional Items
0.22
0.00
0.00
0.00
0.18
0.13
0.00
Gross Profit (PBDT)
281.31
209.82
141.86
54.17
80.97
224.63
335.54
Depreciation
93.77
102.55
87.36
87.27
80.89
46.21
34.58
Profit Before Tax
68.45
-17.16
-62.91
-216.64
-160.91
28.84
107.97
Tax
20.98
-13.27
-24.46
-48.03
-31.80
6.35
17.94
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
47.29
1.50
-39.63
-162.38
-130.77
22.49
90.04
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
47.29
1.50
-39.63
-162.38
-130.77
22.49
90.04
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.18
-5.39
-3.77
-10.93
-0.53
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
47.47
-3.89
-43.40
-173.31
-131.30
22.49
90.04
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
927.64
866.89
819.96
847.08
927.84
1,077.87
1,098.51
Earnings per share (EPS)
0.11
0.0
-0.1
-0.4
-0.32
0.05
0.22
Diluted Earnings per share
0.11
0.0
-0.1
-0.4
-0.32
0.05
0.22
Operating Profit Margin (Excl OI)
9.21%
-9.92%
-21.81%
-115.81%
-86.14%
2.96%
23.18%
Gross Profit Margin
31.23%
18.76%
7.16%
-67.35%
-41.5%
23.16%
32.98%
PAT Margin
9.1%
0.33%
-11.61%
-84.54%
-67.82%
6.94%
20.83%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 14.15% vs 33.30% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 1,317.95% vs 91.01% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 146.69% vs 344.96% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -8.62% vs 48.72% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Sino Medical Sciences Technology, Inc. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
519.48
0
519.48
Other Operating Income
0.00
0.00
0.00
Total Operating income
519.48
0
519.48
Raw Material Cost
238.17
0
238.17
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
200.07
0
200.07
Power Cost
0
0
0.00
Manufacturing Expenses
5.26
0
5.26
Selling and Distribution Expenses
143.02
0
143.02
Other Expenses
-11.85
0.00
-11.85
Total Expenditure (Excl Depreciation)
468.01
0
468.01
Operating Profit (PBDIT) excl Other Income
51.46
0.00
51.46
Other Income
25.63
0
25.63
Operating Profit (PBDIT)
167.26
0
167.26
Interest
5.26
0
5.26
Exceptional Items
0.22
0
0.22
Gross Profit (PBDT)
281.31
0
281.31
Depreciation
93.77
0
93.77
Profit Before Tax
68.45
0
68.45
Tax
20.98
0
20.98
Provisions and contingencies
0
0
0.00
Profit After Tax
47.29
0
47.29
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
47.29
0
47.29
Share in Profit of Associates
0
0
0.00
Minority Interest
0.18
0
0.18
Other related items
0.00
0.00
0.00
Consolidated Net Profit
47.47
0
47.47
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
927.64
0
927.64
Earnings per share (EPS)
0.11
0
0.11
Diluted Earnings per share
0.11
0
0.11
Operating Profit Margin (Excl OI)
9.21%
0%
0.00
9.21%
Gross Profit Margin
31.23%
0%
0.00
31.23%
PAT Margin
9.10%
0%
0.00
9.10%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 51.95 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 14.15% vs 33.30% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 4.75 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 1,317.95% vs 91.01% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.16 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 146.69% vs 344.96% in Dec 2024
Annual - Interest
Interest 0.53 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -8.62% vs 48.72% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.21%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






